Search results

Selected filters:

News
Life Sciences

Article type

Topic

Sector

Regions

Year

146 results found for your search

Sort options
06 March 2019

The state of play in the global IP market

IAM's annual benchmarking survey is designed to identify the key concerns of senior decision makers in areas such as deal-making, valuation, patent office performance, top litigation venues and policy 

18 February 2019

Rolling the dice on eligibility

Congressional action is the only way to solve the uncertainty on section 101 of the US patent statute, argues Aaric Eisenstein of Personalised Media Communications

18 February 2019

Patent deals show how Indian startups can benefit from multinational research activity

An AI health-tech startup recently named one of the world's most promising had its roots in the re-organisation of Xerox's research centre in India

14 February 2019

The five key takeaways from the USPTO’s report on women and patents

Although female patentees are becoming more common – particularly in areas such as pharma and biotech – the rate of growth is slowing, suggesting that a lot more work needs to be done before equality between the sexes is achieved

13 February 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco 

09 February 2019

The big life sciences patent developments in January

Record-breaking Celgene purchase, two decisions on the on-sale bar, Europe moves towards SPC manufacturing waiver, China proposes five-year patent term extension and much more

06 February 2019

Help to find the IP Hall of Fame inductees for 2019

The annual search for outstanding individuals to induct into the IP Hall of Fame starts today and we want your help.

05 February 2019

USPTO rules on patent term adjustment set to change following CAFC decision

The Federal Circuit’s precedential judgment in Supernus Pharmaceuticals v Iancu is good news for rights holders – especially those in life sciences

04 February 2019

New names added to <em>IAM</em>'s list of Asia-Pac's market-leading IP operations

The Asia IP Elite identifies companies and institutions in the region that have world class IP functions. Here we introduce the 18  latest additions and explain why they have made the cut

01 February 2019

Getting to the heart of the life sciences patent debate

SPC disputes, second medical use issues, pharma UPC strategies, CRISPR and much more from IAM’s third annual  pharma and biotech IP conference, which took place in London earlier this week

31 January 2019

Pressure piles on US pharma and biotech IP owners

America's life sciences innovators face accusations of using patents to build monopolies and overcharge for vital medicines. If they do not tell their side of the story and fast, they risk losing vital protections on which they rely   

30 January 2019

Winners of the inaugural Global IP Awards named at gala dinner in London

Law and attorney firms from around the world recognised for their outstanding work in litigation, prosecution and transactions during 2018

23 January 2019

Kokes hails "fantastic first year" as NantWorks CIPO

In exclusive interview with IAM, after confirming as a speaker for IPBC Global 2019, the former BlackBerry IP chief talks in-depth about life sciences and high tech convergence - and the many patent opportunities that creates 

23 January 2019

Welcome to the future of patents

New IAM research reports identify the key trends shaping the global IP market – and tell you how to respond

22 January 2019

Bridgestone's TomTom acquisition shows that data is the new gold rush

The $1 billion deal emphasises that for IP professionals a detailed understanding of data-related issues is set to become essential